Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.
about
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Anticancer activity of Aristolochia ringens Vahl. (Aristolochiaceae).A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer.Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.Anticancer activity of the phytomedicine DAS-77.Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticalsTriple blockade of HER2 by a cocktail of anti-HER2 scFv antibodies induces high antiproliferative effects in breast cancer cells.Breast Cancer Vaccines: New Insights.Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy RoadPolyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
P2860
Q33653836-453FE2DF-A565-437A-8701-952290C39B27Q33786788-B28F69B8-0C39-43CA-A954-A511FA2DD2CCQ35806896-E0BFE623-B9FD-4121-A72C-777254058272Q36757173-B018DA86-CEEB-4F1F-87F8-9C967FCDED8CQ37078963-92341511-B5AA-4CFD-AD2E-4384C3C7A095Q38685586-CE6081D7-C02E-4938-A062-956D0D08CB0AQ38944452-EF63F070-7DCA-47B5-9FCC-3ED01FEB86F4Q38957698-9FF01CC3-C1C5-4425-829D-596E19C597D7Q38995018-EFBE7436-96F2-49A1-A35F-F06095602666Q42683276-51B4E42D-6271-4E90-B541-B5E12E7AF275Q52763519-FA2624AB-F112-42B1-B84F-C7D166F645EBQ58750585-463D4BC1-5402-4C6B-82EC-FD9B505C1652Q58793646-BC8781A5-5CCA-4EAF-BF5A-7D24955D2D14
P2860
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@ast
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@en
type
label
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@ast
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@en
prefLabel
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@ast
Polyclonal HER2-specific antib ...... nd degradation in tumor cells.
@en
P2093
P2860
P356
P1476
Polyclonal HER2-specific antib ...... and degradation in tumor cells
@en
P2093
Amy C Hobeika
Erika Hamilton
Gangjun Lei
Jiangbo Wang
Junping Wei
Kimberly Blackwell
Larry S Barak
Michael A Morse
Neil Spector
P2860
P2888
P356
10.1186/BCR3204
P577
2012-06-07T00:00:00Z
P5875
P6179
1050546753